Vir Biotechnology (NASDAQ:VIR) Price Target Raised to $31.00 at Barclays
Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its target price increased by equities researchers at Barclays from $26.00 to $31.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 269.49% from the stock’s current price. […]
Vir Biotechnology (NASDAQ:VIR – Get Free Report) had its target price increased by equities researchers at Barclays from $26.00 to $31.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 269.49% from the stock’s current price. […]
